A detailed history of Belvedere Trading LLC transactions in Alector, Inc. stock. As of the latest transaction made, Belvedere Trading LLC holds 10,486 shares of ALEC stock, worth $13,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,486
Holding current value
$13,002
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$1.42 - $3.18 $14,890 - $33,345
10,486 New
10,486 $31,000
Q3 2021

Oct 19, 2021

SELL
$21.65 - $39.49 $534,993 - $975,837
-24,711 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$15.5 - $22.48 $383,020 - $555,503
24,711 New
24,711 $804,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $102M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.